Schedule 13G ownership disclosure

XILIO THERAPEUTICS INC

Security class unavailable · CUSIP: 98422T100

Event date: 2024-06-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,000,000
Percent of class
15.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001068238-24-000192
Form type
SC 13G
Filer
GKCC, LLC
CIK
CIK 1977769
Filed
Sep 27, 2024
Reporting period
Jun 07, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub